Zobrazeno 1 - 2
of 2
pro vyhledávání: '"HbA1c composite endpoint"'
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 4, Iss 1, Pp 1-11 (2018)
Abstract Background To identify baseline/clinical characteristics associated with clinically meaningful responses to insulin glargine 100 U/mL (IGlar) in insulin-naive people with type 2 diabetes mellitus (T2DM). Methods Individual participant data w
Externí odkaz:
https://doaj.org/article/9cd60482c4244802858625681dbc1178
Autor:
Cummings MH; 1Queen Alexandra Hospital, Portsmouth, UK., Cao D; 2Eli Lilly and Company, Indianapolis, IN USA., Hadjiyianni I; 3Lilly Deutschland GmbH, Bad Homburg, Germany., Ilag LL; 2Eli Lilly and Company, Indianapolis, IN USA., Tan MH; 4University of Michigan, Ann Arbor, MI USA.
Publikováno v:
Clinical diabetes and endocrinology [Clin Diabetes Endocrinol] 2018 May 08; Vol. 4, pp. 10. Date of Electronic Publication: 2018 May 08 (Print Publication: 2018).